Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation

Regression modeling of competing risk using R: an in depth guide for clinicians

(2010) L Scrucca et al.   BONE MARROW TRANSPLANTATION

Infectious Complications after Unrelated Umbilical Cord Blood Transplantation in Adult Patients with Hematologic Malignancies

(2009) Xavier Cahu et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Impact of Cyclosporine-A Concentration on the Incidence of Severe Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation

(2009) Florent Malard et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Monitoring and Preemptive Rituximab Therapy for Epstein-Barr Virus Reactivation after Antithymocyte Globulin Containing Nonmyeloablative Conditioning for Umbilical Cord Blood Transplantation

(2009) Anne H. Blaes et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

How I treat EBV lymphoproliferation

(2009) H. E. Heslop   BLOOD

Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?

(2009) B. N. Savani et al.   BLOOD

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

(2009) H. E. Heslop et al.   BLOOD

Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source

(2009) P Chevallier et al.   BONE MARROW TRANSPLANTATION

Reduced-intensity conditioning for allogeneic stem cell transplantation: 10 years later

(2009) Mohamad Mohty et al.   CURRENT OPINION IN ONCOLOGY

Reduced-intensity conditioning transplantation in myeloid malignancies

(2009) Rainer Storb   CURRENT OPINION IN ONCOLOGY

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

(2008) J Styczynski et al.   BONE MARROW TRANSPLANTATION

Cellular normalization of viral DNA loads on whole blood improves the clinical management of cytomegalovirus or Epstein Barr virus infections in the setting of pre-emptive therapy

(2008) Céline Bressollette-Bodin et al.   JOURNAL OF MEDICAL VIROLOGY